Evolan Pharma completed the acquisition of Hydrokortison Trimb from Karo Pharma.

Evolan Pharma, a pharmaceutical company in Sweden, completed the acquisition of Hydrokortison Trimb, an OTC pharmaceutical product provider, from Karo Pharma, a pharmaceutical company. Financial terms were not disclosed. During the financial year 2018, the total sales of Hydrokortison Trimb amounted to SEK 19.8m.